Decoding the Limits of Deep Learning in Molecular Docking for Drug Discovery

Ting Li; Jiacai Yi; Hui Li; Kun Li; Fenghua Kang; Youchao Deng; Chengkun Wu; Xiangzheng Fu; Dejun Jiang; Dongsheng Cao

doi:10.1039/d5sc05395a

January 1, 2025Chemical ScienceOpen Access

Decoding the Limits of Deep Learning in Molecular Docking for Drug Discovery

View Full Paper

Ask AI

Bookmark

Share

Key Points

Deep learning reveals limitations in molecular docking for drug discovery, indicating a need for critical evaluation.
Key evidence shows emerging deep learning techniques may not always enhance molecular docking outcomes significantly.
Assessment using structure-based molecular docking methodologies uncovers challenges in dynamics and accuracy.
This research highlights potential issues in deep learning approaches applied to drug discovery, calling for careful consideration.

Implication

Observational analysis highlights limitations of deep learning in molecular docking for drug discovery, suggesting caution in method deployment.

Abstract

Structure-based molecular docking, a cornerstone of computational drug design, is undergoing a paradigm shift fueled by deep learning (DL) innovations. However, the rapid proliferation of DL-driven docking methods has created...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68af453fad7bf08b1ead2cf0 https://doi.org/10.1039/d5sc05395a

View Full Paper

Ask AI

Bookmark

Share

Decoding the Limits of Deep Learning in Molecular Docking for Drug Discovery

Key Points

Implication

Abstract

Discussion

Cite This Study

Decoding the Limits of Deep Learning in Molecular Docking for Drug Discovery

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading